Reports Corner has
added “Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and
Procurement Strategies in the Global Pharmaceutical Industry” to its latest
reports offering. Please visit the link (https://www.reportscorner.com/report_detail.php?r_id=9823
)
Product
Synopsis
“Global
Pharmaceutical Survey 2013-2014: Market Trends, Buyer Spend and Procurement
Strategies in the Global Pharmaceutical Industry” is a new report by ICD
Research that analyzes how pharmaceutical industry companies' procurement
expenditures, business strategies, and practices are set to change in
2013-2014. Additionally, this report also presents comparative analysis between
four years of survey results (wherever applicable). This report gives access to
category-level spending outlooks, budgets, supplier selection criteria,
business challenges, and investment opportunities of leading purchase decision
makers. The report also identifies the future growth of buyers and suppliers,
MandA, capital expenditure, staff hiring, and e-procurement. This report not only
grants access to the opinions and strategies of business decision makers and
competitors, but also examines their actions surrounding business priorities,
as well as access to information categorized by region, company type, and size.
Introduction
and Landscape
Why was the report
written?This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading global pharmaceutical industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global pharmaceutical industry. The report includes key topics such as global pharmaceutical industry buyer expenditure and procurement behaviours and strategies, and identifies the threats and opportunities within the global pharmaceutical industry, economic outlook trends, and business confidence within global pharmaceutical executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives' attitude and changing behaviours, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, ICD Research created this primary-research based report by gathering the opinions of multiple stakeholders in the value-chain of the global pharmaceutical industry.
What is the current
market landscape and what is changing?
Executives from the
global pharmaceutical industry anticipate an increase in levels of
consolidation, with 61% of respondents projecting an increase in MandA
activities in 2013.
What are the key
drivers behind recent market changes?
The need for new
product pipelines, new product acquisition, patent expiries, cost containment
and credit availability have prompted companies to consolidate positions and
look for merger and MandA acquisition.
What makes this
report unique and essential to read?
This report is the
result of an extensive survey drawn from ICD Research's exclusive panel of
leading global pharmaceutical industry executives; it provides data and
analysis on buyer expenditure, procurement, and developments within the global
pharmaceutical industry. The report includes key topics such as global
pharmaceutical industry buyer expenditure and procurement behaviours and
strategies, and identifies the threats and opportunities within the global
pharmaceutical industry, economic outlook trends, and business confidence
within global pharmaceutical industry executives. Additionally, this report
also presents comparative analysis between four years of survey results
(wherever applicable).
Key
Features and Benefits
Project industry
trends and revenue growth expectations in 2013, and understand business
confidence to make informed business decisions.
Drive revenues by
understanding future product investment areas and key growth regions.
Uncover key
challenges and opportunities, and identify the key actions required to maintain
and win buyer business.
Formulate effective
sales and marketing strategies by identifying how buyer budgets are changing
and the direction of spending in the future. Better promote your business by
aligning your capabilities and business practices with your customer's changing
needs
Secure stronger
customer relationships by understanding the behaviour and changing strategies
of industry buyers.
Key
Market Issues
China, Brazil and
India are the important emerging markets to offer growth in 2013.
'Market uncertainty',
'responding to price pressure', 'rising competition' and 'regulatory changes'
are the leading business concerns for the global pharmaceutical industry in
2013.
Overall, for 2013,
the average size of the annual procurement budget for global pharmaceutical
industry buyer respondents is projected at US$127 million, against US$127
million in 2012 and US$110 million in 2011.
'Price', 'level of
service' and 'existing relationship with supplier' are considered the most
important factors for supplier selection in the global pharmaceutical industry,
while 'environmental records and CSR',
'brand reputation' and 'proximity of supplier operations' are considered the
least important.
While 16% of buyer
respondents from the global pharmaceutical industry are willing to implement
e-procurement in 2013 or beyond, 32% are already in the different stages of
implementation ('partially implemented', 'completely implemented', and
'evaluation or pilot use')
Key
Highlights
An analysis of
revenue growth expectations by senior level respondents reveals that 62% are
'more optimistic' about their company's revenue growth in 2013.
A significant
percentage of pharmaceutical manufacturing industry respondents highlighted
that capital expenditure towards 'new product development', 'employee
training', and 'IT infrastructure development' would increase in 2013.
The top three
priorities for global pharmaceutical industry buyer respondents in 2013 are
'new products and services', 'improve operational efficiency' and 'expand in
current markets'.
A total of 49% of
respondents from pharmaceutical manufacturing companies, 68% of respondents
from CROs and CMOs companies, and 64% of respondents from pharmaceutical
industry supplier companies anticipate an increase of their current workforce
in 2013.
Survey results show
that respondents from the global pharmaceutical industry identified the US to
offer the highest growth potential among developed countries in 2013-2014.
Table
of Contents
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents:
Global Pharmaceutical Industry
1.4.1 Global pharmaceutical industry:
profile of buyer respondents
1.4.2 Global pharmaceutical industry:
profile of supplier respondents
2 Executive Summary
3 Global Pharmaceutical Industry
Dynamics
3.1 Revenue Growth Projections in the
Global Pharmaceutical Industry
3.1.1 Revenue growth projections by
company type
3.1.2 Revenue growth projections by
region
3.1.3 Revenue growth projections by
company turnover
3.1.4 Global pharmaceutical industry:
revenue growth expectations by senior level respondents
3.2 Future Developments in Business
Structure in the Global Pharmaceutical Industry
3.2.1 Future developments in business
structure by buyers
3.2.2 Future developments in business
structure by suppliers
3.2.3 Future developments in business
structure by region
3.2.4 Future developments in business
structure by company turnover
3.2.5 Future developments in business
structure by senior level respondents
3.3 Change in Leading Company
Strategies in the Global Pharmaceutical Industry
3.3.1 Change in leading company
strategies by buyers
3.3.2 Change in leading company
strategies by suppliers
3.3.3 Change in leading company
strategies by region
3.3.4 Change in leading company
strategies by company turnover
3.4 Merger and Acquisition (MandA)
Activity Projections in the Global Pharmaceutical Industry
3.4.1 MandA activity projections by
buyers
3.4.2 MandA activity projections by
suppliers
3.4.3 MandA activity projections by region
3.4.4 MandA activity projections by
company turnover
3.4.5 MandA activity projections by
purchasing decision authority
3.4.6 Global pharmaceutical industry -
expand abroad Vs MandA activity projections
3.5 Estimation of Capital Expenditure
in the Global Pharmaceutical Industry
3.5.1 Estimation of capital
expenditure by buyers
3.5.2 Estimation of capital
expenditure by suppliers
3.5.3 Estimation of capital
expenditure by region
3.5.4 Estimation of capital
expenditure by company turnover
3.6 Planned Change in Staff
Recruitment Activity in the Global Pharmaceutical Industry
3.6.1 Planned change in staff
recruitment activity by buyers
3.6.2 Planned change in staff
recruitment activity by suppliers
3.6.3 Planned change in staff
recruitment activity by region
3.6.4 Planned change in staff
recruitment activity by company turnover
4 Global Pharmaceutical Industry
Market Growth Outlook
4.1 Global Pharmaceutical Industry:
Demand in Emerging Markets
4.1.1 Demand in emerging markets by
buyers
4.1.2 Demand in emerging markets by
suppliers
4.1.3 Demand in emerging markets by
region
4.1.4 Demand in emerging markets by
company turnover
4.2 Global Pharmaceutical Industry -
Growth Projections in Developed Countries
4.2.1 Growth projections in developed
countries by buyers
4.2.2 Growth projections in developed
countries by suppliers
4.2.3 Growth projections in developed
countries by region
4.2.4 Growth projections in developed
countries by company turnover
5 Threats and Opportunities for the
Global Pharmaceutical Industry
5.1 Global Pharmaceutical Industry:
Leading Business Concerns for 2013-2014
5.1.1 Leading business concerns for
2013-2014 by company type
5.1.2 Leading business concerns for
2013-2014 by region
5.1.3 Leading business concerns for
2013-2014 by company turnover
5.2 Global Pharmaceutical Industry:
Key Supplier Actions to Maintain and Win Buyer Business
5.2.1 Actions to maintain and secure
buyer business by buyers
5.2.2 Actions to maintain and secure
buyer business by region
5.2.3 Actions to maintain and secure
buyer business by company turnover
5.2.4 Actions to maintain and secure
buyer business by purchasing decision authority
6 Global Pharmaceutical Industry Buyer
Expenditure Activity
6.1 Annual Procurement Budgets in the
Global Pharmaceutical Industry
6.1.1 Revenue growth vs. procurement
budget
6.1.2 Annual procurement budgets by
company type
6.1.3 Annual procurement budgets by
region
6.1.4 Annual procurement budgets by
company turnover
6.1.5 Annual procurement budgets by
senior level respondents
6.2 Planned Change in Procurement
Expenditure in the Global Pharmaceutical Industry
6.2.1 Planned change in procurement
expenditure by buyer type
6.2.2 Planned change in procurement
expenditure by region
6.2.3 Planned change in procurement
expenditure by company turnover
6.2.4 Planned change in procurement
expenditure vs. revenue growth optimism
6.2.5 Planned change in procurement
expenditure vs. cost containment
6.3 Planned change in Procurement
Expenditure by Product and Service Category
6.3.1 Planned change in procurement
expenditure by product and service category - region
6.3.2 Planned change in procurement
expenditure by product and service category - company turnover
6.4 Global Pharmaceutical Industry:
Variations in Regional Supplier Prices
6.4.1 Variations in regional supplier
prices by company type
6.4.2 Variations in regional supplier
prices by region
6.4.3 Variations in regional supplier
prices by company turnover
7 Global Pharmaceutical Industry:
Procurement Behaviors and Strategies
7.1 Global Pharmaceutical Industry:
Critical Success Factors for Supplier Selection
7.2 E-procurement in the Global
Pharmaceutical Industry
7.2.1 E-procurement in the global
pharmaceutical industry by buyer type
7.2.2 E-procurement in the global
pharmaceutical industry by region
7.2.3 E-procurement in the global
pharmaceutical industry by company turnover
8 Appendix
8.1 Global Pharmaceutical Industry
Survey Results- Closed Questions
8.2 Methodology
8.3 Contact us
8.4 About ICD Research
8.5 Disclaimer
List
of Tables
Table 1: Global Pharmaceutical
Industry Survey Respondents by Company Type, 2013
Table 2: Global Pharmaceutical
Industry Buyer Respondents by Job Role (%), 2013
Table 3: Global Pharmaceutical
Industry Buyer Respondents by Region (%), 2013
Table 4: Global Pharmaceutical
Industry Buyer Respondents by Company Turnover (%), 2013
Table 5: Global Pharmaceutical
Industry Supplier Respondents by Job Role (%), 2013
Table 6: Global Pharmaceutical
Industry Supplier Respondents by Region (%), 2013
Table 7: Global Pharmaceutical
Industry Supplier Respondents by Company Turnover (%), 2013
Table 8: Revenue Growth Optimism in
the Global Pharmaceutical Industry (%), 2010-2013
Table 9: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Buyers (%), 2010-2013
Table 10: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Suppliers (%), 2010-2013
Table 11: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Region (%),2013
Table 12: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Turnover (%), 2013
Table 13: Revenue Growth Optimism by
Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
Table 14: Key Expected Changes in
Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
Table 15: Key Expected Changes in
Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
Table 16: Key Expected Changes in
Business Structure by Turnover - Global Pharmaceutical Industry (%), 2013
Table 17: Key Expected Changes In
Business Structure by Senior Level Respondents - Global Pharmaceutical Industry
(%), 2013
Table 18: Change in Leading Company
Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
Table 19: Change in Leading Company
Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
Table 20: Change in Leading Company
Strategies by Region - Global Pharmaceutical Industry (%), 2013
Table 21: MandA Activity Projections -
Global Pharmaceutical Manufacturers' Industry (%), 2010-2013
Table 22: MandA Activity Projections -
Global CROs and CMOs (%), 2010-2013
Table 23: MandA Activity Projections -
Global Pharmaceutical Industry Suppliers (%), 2010-2013
Table 24: Global Pharmaceutical
Industry MandA Activity Projections by Region (%), 2013
Table 25: Global Pharmaceutical
Industry MandA Activity Projections by Turnover (%), 2013
Table 26: Global Pharmaceutical
Industry MandA Activity Projections by Purchasing Decision Authority (%), 2013
Table 27: Global Pharmaceutical
Industry - Expand Abroad vs. MandA Activity Projections(%), 2013
Table 28: Change in Capital
Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
Table 29: Change in Capital
Expenditure by Global CROs and CMOs (%), 2013
Table 30: Change in Capital
Expenditure by Pharmaceutical Industry Suppliers (%), 2013
Table 31: Global Pharmaceutical
Industry - Increase in Capital Expenditure by Region (%), 2013
Table 32: Global Pharmaceutical
Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
Table 33: Global Pharmaceutical
Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
Table 34: Global Pharmaceutical
Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
Table 35: Global Pharmaceutical
Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
Table 36: Global Pharmaceutical Industry
Manufacturers - Demand in Emerging Markets (%), 2013
Table 37: Global Pharmaceutical
Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
Table 38: Global Pharmaceutical
Industry Suppliers - Demand in Emerging Markets (%), 2013
Table 39: Global Pharmaceutical
Manufacturers- Growth Projections in Developed Countries (%), 2013
Table 40: Global Pharmaceutical CROs
and CMOs- Growth Projections in Developed Countries (%), 2013
Table 41: Global Pharmaceutical
Industry Suppliers - Growth Projections in Developed Countries (%), 2013
Table 42: Global Pharmaceutical
Industry - Increase in Growth Projections of Developed Countries by Turnover
(%), 2013
Table 43: Global Pharmaceutical
Industry - Leading Business Concerns (%), 2010-2013
Table 44: Global Pharmaceutical
Industry - Leading Business Concerns by Company Type (%), 2013
Table 45: Global Pharmaceutical
Industry - Leading Business Concerns by Region (%), 2013-2014
Table 46: Global Pharmaceutical
Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
Table 47: Actions to Secure Buyer
Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
Table 48: Global Pharmaceutical
Industry - Securing Buyer Business by Turnover (%), 2013
Table 49: Securing Buyer Business in
the Global Pharmaceutical Industry - by
Purchasing Decision Authority (%), 2013
Table 50: Annual Procurement Budgets
of Global Pharmaceutical Industry Manufacturers in US$ (%), 2010-2013
Table 51: Global Pharmaceutical
Industry Buyers - Increase in Revenue Growth vs. Procurement Budget (%), 2013
Table 52: Global Pharmaceutical
Industry Buyers - Annual Procurement Budgets in US$ by Buyer Type (%), 2013
Table 53: Global Pharmaceutical
Industry Buyers - Annual Procurement Budgets in US$ by Region(%), 2013
Table 54: Global Pharmaceutical
Industry Buyers - Annual Procurement Budgets in US$ by Turnover (%), 2013
Table 55: Global Pharmaceutical
Industry - Annual Procurement Budgets in US$ by Senior Level Respondents (%), 2013
Table 56: Change in Procurement
Expenditure - Global Pharmaceutical Industry Buyers (%), 2010-2013
Table 57: Global Pharmaceutical
Industry - Change in Procurement Expenditure by Buyer Type (%), 2013
Table 58: Global Pharmaceutical
Industry - Change in Procurement Expenditure by Region (%), 2013
Table 59: Global Pharmaceutical
Industry - Change in Procurement Expenditure by Turnover (%), 2013
Table 60: Global Pharmaceutical
Industry - Change in Procurement Expenditure vs. Revenue Growth (%), 2013
Table 61: Global Pharmaceutical
Industry - Change in Procurement Expenditure vs. Cost Containment (%), 2013
Table 62: Future Change in Expenditure
by Product and Service Category, Pharmaceutical Industry Manufacturers (%),
2013
Table 63: Future Change in Expenditure
by Product and Service Category, CROs and CMOs (%), 2013
Table 64: Increase in Expenditure by
Product and Service Category - Buyers by Region , 2013
Table 65: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices (%), 2013
Table 66: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices by Company Type (%), 2013
Table 67: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices by Region (%), 2013
Table 68: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices by Turnover (%), 2013
Table 69: Critical Success Factors for
Supplier Selection - Global Pharmaceutical Industry Buyers, 2013
Table 70: E-Procurement - Level of
Implementation in the Global Pharmaceutical Industry (%), 2013
Table 71: E-Procurement in the Global
Pharmaceutical Industry: by Buyer Type(%), 2013
Table 72: E-Procurement in the Global
Pharmaceutical Industry by Region (%), 2013
Table 73: E-Procurement in the Global
Pharmaceutical Industry by Turnover (%), 2013
Table 74: Survey Results - Closed
Questions
List
of Figures
Figure 1: Revenue Growth Optimism in
the Global Pharmaceutical Industry (%), 2010-2013
Figure 2: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Company Type (%), 2010-2013
Figure 3: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Region (%), 2013
Figure 4: Revenue Growth Optimism in
the Global Pharmaceutical Industry by Turnover (%), 2013
Figure 5: Revenue Growth Optimism by
Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
Figure 6: Key Expected Changes in
Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
Figure 7: Key Expected Changes in
Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
Figure 8: Key Expected Changes in
Business Structure by Region - Global Pharmaceutical Industry (%), 2013
Figure 9: Change in Leading Company
Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
Figure 10: Change in Leading Company
Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
Figure 11: Change in Leading Company
Strategies by Region - Global Pharmaceutical Industry (%), 2013
Figure 12: Change in Leading Company
Strategies by Turnover - Global Pharmaceutical Industry (%), 2013
Figure 13: MandA Activity Projections
- Global Pharmaceutical Industry (%), 2013
Figure 14: MandA Activity Projections
- Global Pharmaceutical Manufacturers' Industry (%), 2010-2013
Figure 15: MandA Activity Projections
- Global CROs and CMOs (%), 2010-2013
Figure 16: MandA Activity Projections
- Global Pharmaceutical Industry Suppliers (%), 2010-2013
Figure 17: Global Pharmaceutical
Industry MandA Activity Projections by Region (%), 2013
Figure 18: Global Pharmaceutical
Industry MandA Activity Projections by Turnover (%), 2013
Figure 19: Global Pharmaceutical
Industry MandA Activity Projections by Purchasing Decision Authority (%), 2013
Figure 20: Global Pharmaceutical
Industry - Expand Abroad Vs MandA Activity Projections (%), 2013
Figure 21: Change in Capital
Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
Figure 22: Change in Capital
Expenditure by Global CROs and CMOs (%), 2013
Figure 23: Change in Capital
Expenditure by Pharmaceutical Industry Suppliers (%), 2013
Figure 24: Global Pharmaceutical
Industry - Increase in Capital Expenditure by Turnover (%), 2013
Figure 25: Global Pharmaceutical
Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
Figure 26: Global Pharmaceutical
Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
Figure 27: Global Pharmaceutical Industry
- Planned Change in Staff Recruitment Activity by Region (%), 2013
Figure 28: Global Pharmaceutical
Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
Figure 29: Global Pharmaceutical
Industry: Top Ten Growth Regions (%), 2013
Figure 30: Global Pharmaceutical
Industry: Top Five Emerging Markets, 2013
Figure 31: Global Pharmaceutical
Industry Manufacturers - Demand in Emerging Markets (%), 2013
Figure 32: Global Pharmaceutical
Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
Figure 33: Global Pharmaceutical
Industry Suppliers - Demand in Emerging Markets (%), 2013
Figure 34: Global Pharmaceutical
Industry - Demand in Emerging Markets by Region (%), 2013
Figure 35: Global Pharmaceutical
Industry - Demand in Emerging Markets by Turnover (%), 2013
Figure 36: Global Pharmaceutical
Industry - Top Five Developed Regions by Growth (%), 2013
Figure 37: Global Pharmaceutical
Manufacturers- Growth Projections in Developed Countries (%), 2013
Figure 38: Global Pharmaceutical CROs
and CMOs- Growth Projections in Developed Countries (%), 2013
Figure 39: Global Pharmaceutical
Industry Suppliers - Growth Projections in Developed Countries (%), 2013
Figure 40: Global Pharmaceutical
Industry - Increase in Growth Projections of Developed Countries by Region (%),
2013
Figure 41: Global Pharmaceutical
Industry - Top Five Leading Business Concerns, 2013
Figure 42: Global Pharmaceutical
Industry - Leading Business Concerns (%), 2013
Figure 43: Global Pharmaceutical Industry
- Leading Business Concerns by Company Type (%), 2013
Figure 44: Global Pharmaceutical
Industry - Leading Business Concerns by Turnover (%), 2013-2014
Figure 45: Global Pharmaceutical
Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
Figure 46: Actions to Secure Buyer
Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
Figure 47: Global Pharmaceutical
Industry - Securing Buyer Business by Region (%), 2013
Figure 48: Annual Procurement Budgets
of Global Pharmaceutical Industry Manufacturers in US$ (%), 2010-2013
Figure 49: Global Pharmaceutical
Industry Buyers - Annual Procurement Budgets in US$ by Buyer Type (%), 2013
Figure 50: Global Pharmaceutical
Industry Buyers - Annual Procurement Budgets in US$ by Turnover (%), 2013
Figure 51: Global Pharmaceutical
Industry - Annual Procurement Budgets in US$ by Senior Level Respondents (%),
2013
Figure 52: Change in Procurement
Expenditure - Global Pharmaceutical Industry Buyers (%), 2010-2013
Figure 53: Global Pharmaceutical
Industry - Change in Procurement Expenditure by Buyer Type (%), 2013
Figure 54: Global Pharmaceutical
Industry - Change in Procurement Expenditure by Region (%), 2013
Figure 55: Global Pharmaceutical
Industry - Change in Procurement Expenditure by Turnover (%), 2013
Figure 56: Future Change in
Expenditure by Product and Service Category, Buyers , 2013
Figure 57: Future Change in
Expenditure by Product and Service Category, Pharmaceutical Industry
Manufacturers (%), 2013
Figure 58: Future Change in
Expenditure by Product and Service Category, CROs and CMOs (%), 2013
Figure 59: Increase in Expenditure by
Product and Service Category - Buyers by Turnover (%), 2013
Figure 60: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices (%), 2013
Figure 61: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices by Company Type (%), 2013
Figure 62: Global Pharmaceutical
Industry - Variations in Regional Supplier Prices by Region (%), 2013
Figure 63: Critical Success Factors
for Supplier Selection - Global Pharmaceutical Industry Buyers, 2013
Figure 64: E-Procurement - Level of
Implementation in the Global Pharmaceutical Industry (%), 2013
Figure 65: E-Procurement in the Global
Pharmaceutical Industry: by Buyer Type(%), 2013
Figure 66: E-Procurement in the Global
Pharmaceutical Industry by Region (%), 2013
Figure 67: E-Procurement in the Global
Pharmaceutical Industry: by Turnover (%), 2013
No comments:
Post a Comment